Effects of physiologically relevant dynamic shear stress on platelet complement activation

Platelets

Volumn 22, Issue 8, 2011, Pages 602-610

  Shanmugavelayudam, Saravan Kumar ^a   Rubenstein, David A ^a   Yin, Wei ^a  

^a Oklahoma State University   (United States)

Author keywords

Complement activation; Coronary heart disease; Platelet; Shear stress

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4D; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SC5B 9; UNCLASSIFIED DRUG;

ARTICLE; CIRCULATION; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEFT CORONARY ARTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SHEAR STRESS; SHIFT TO THE RIGHT; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

ADENOSINE DIPHOSPHATE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PLATELETS; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT SYSTEM PROTEINS; HUMANS; PLATELET ACTIVATION; PROTEIN BINDING; SHEAR STRENGTH; STRESS, PHYSIOLOGICAL;

EID: 80455168371     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.585257     Document Type: Article

References (33)

1. Torzewski J, Bowyer DE, Waltenberger J, Fitzsimmons C. Processes in atherogenesis: Complement activation. Atherosclerosis 1997;2:131-138. (Pubitemid 27311003)
2. Peerschke EI, Minta JO, Zhou SZ, Bini A, Gotlieb A, Colman RW, Ghebrehiwet B. Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions. Mol Immunol 2004;8:759-766. (Pubitemid 38953633)
3. Rus HG, Niculescu F, Constantinescu E, Cristea A, Vlaicu R. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. Atherosclerosis 1986;1:35-42. (Pubitemid 16098888)
4. Vlaicu R, Rus HG, Niculescu F, Cristea A. Quantitative determinations of immunoglobulins and complement components in human aortic atherosclerotic wall. Med Interne 1985;1:29-35. (Pubitemid 15027654)
5. Vlaicu R, Niculescu F, Rus HG, Cristea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 1985;2-3:163-177. (Pubitemid 16235906)
6. Yasojima K, Schwab C, McGeer EG, McGeer PL. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;7:1214-1219. (Pubitemid 34215153)
7. Williams TJ. Vascular permeability changes induced by complement-derived peptides. Agents Actions 1983;5-6: 451-455.
8. Oksjoki R, Laine P, Helske S, Vehmaan-Kreula P, Mayranpaa MI, Gasque P, Kovanen PT, Pentikainen MO. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. Atherosclerosis 2007;1:90-99. (Pubitemid 47561949)
9. Wootton DM, Ku DN. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng 1999;1: 299-329. (Pubitemid 129740014)
10. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996;5:1525-1541. (Pubitemid 26307046)
11. Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J Thromb Haemost 2006;9:2035-2042. (Pubitemid 44226786)
12. Yin W, Rubenstein AD. Dose effect of shear stress in platelet complement activation in a cone and plate shearing device. Cell Mol Bioeng 2009;2:274-280.
13. del Conde I. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005;6:871-879. (Pubitemid 40524457)
14. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, et al. Generation of C5a in the absence of C3: A new complement activation pathway. Nat Med 2006;6: 682-687. (Pubitemid 43865238)
15. Wiedmer T, Sims PJ. Effect of complement proteins C5b-9 on blood platelets. Evidence for reversible depolarization of membrane potential. J Biol Chem 1985;13:8014-8019. (Pubitemid 15231447)
16. Wiedmer T, Esmon CT, Sims PJ. Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 1986;4:875-880. (Pubitemid 17183846)
17. Schmaier AH, Amenta S, Xiong T, Heda GD, Gewirtz AM. Expression of platelet C1 inhibitor. Blood 1993;2:465-474. (Pubitemid 23206109)
18. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med 1988;5:1699-1717. (Pubitemid 19023257)
19. Ross GD, Lambris JD, Cain JA, Newman SL. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J Immunol 1982;5:2051-2060. (Pubitemid 12004368)
20. Hourcade DE, Mitchell L, Kuttner-Kondo LA, Atkinson JP, Medof ME. Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. J Biol Chem 2002;2:1107-1112. (Pubitemid 34968857)
21. Goto S. Functional significance of adenosine 50-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate. Circulation 2002;21: 2531-2536. (Pubitemid 34568976)
22. Goto S. Effects of adenosine 50-diphosphate (ADP) receptor blockade on platelet aggregation under flow. Blood 2002;12:4644-4645.
23. Moake JL. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988;5: 1366-1374.
24. Shanmugavelayudam SK, Rubenstein DA, Yin W. Effect of geometrical assumptions on numerical modeling of coronary blood flow under normal and disease conditions. J Biomech Eng 2010;6:061004-1-061004-8.
25. Maalej N, Holden JE, Folts JD. Effect of shear stress on acute platelet thrombus formation in canine stenosed carotid arteries: An in vivo quantitative study. J Thromb Thrombolysis 1998;3:231-238. (Pubitemid 28241449)
26. Yin W, Shanmugavelayudam SK, Rubenstein DA. The effect of physiologically relevant dynamic shear stress on platelet and endothelial cell activation. Thromb Res 2011;3:235-241.
27. Chiu JJ, Wang DL, Chien S, Skalak R, Usami S. Effects of disturbed flow on endothelial cells. J Biomech Eng 1998;1:2-8. (Pubitemid 28110431)
28. Chiu JJ, Usami S, Chien S. Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis. Ann Med 2009;1:19-28.
29. Oksjoki R, Kovanen PT, Pentikainen MO. Role of complement activation in atherosclerosis. Curr Opin Lipidol 2003;5:477-482. (Pubitemid 37297302)
30. Hansch GM. Effect of aspirin on the complement system in vitro. Int arch Allergy Appl Immunol 1980;2:150-158.
31. Lee SH. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006;4:370-378.
32. Voigtlander V, Hansch GM, Rother U. Effect of aspirin on complement in vivo. Int Arch Allergy Appl Immunol 1980;2:145-149. (Pubitemid 10185186)
33. Krych-Goldberg M, Hauhart RE, Subramanian VB, Yurcisin BM, Crimmins DL, Hourcade DE, Atkinson JP. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem 1999;44:31160-31168.